Cargando…
The role of synovial fluid cytokines IL-6, IL-23 and IL-17 in the pathogenesis and persistence of synovial inflammation in JIA patients
Autores principales: | Tzimouli, V, Trachana, M, Taparkou, A, Pratsidou-Gertsi, P, Metsovitis, S, Pardalos, G, Kanakoudi-Tsakalidou, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333916/ http://dx.doi.org/10.1186/1546-0096-6-S1-P12 |
Ejemplares similares
-
Impact of a 2-yr anti-TNF treatment on the quality of life in JIA patients: a parent's/patient’s view
por: Diafa, K, et al.
Publicado: (2011) -
The use of Etanercept and Adalimumab in the management of JIA: a 5-year follow-up study
por: Trachana, M, et al.
Publicado: (2008) -
B lymphocyte stimulator, interferon-α and HMGB 1 interrelation in childhood onset systemic lupus erythematosus: associations with disease activity and severity
por: Kanakoudi-Tsakalidou, Florence, et al.
Publicado: (2014) -
The portrait of Familial Mediterranean Fever in N. Greek pediatric patients: a 30-year experience
por: Pratsidou-Gertsi, P, et al.
Publicado: (2015) -
PReS-FINAL-2093: Can clinical response within 12 weeks in JIA-etanercept receivers predict the future clinical remission?
por: Pratsidou-Gertsi, P, et al.
Publicado: (2013)